Colorectal Cancer: New Drugs, Emerging ParadigmsColorectal Cancer: New Drugs, Emerging Paradigms
Dr. John Marshall highlights colorectal studies on aflibercept, regorafenib, maintenance therapy, perioperative chemotherapy, and second-line therapy, to be presented at ASCO® 2012. Medscape Hematology-Oncology (Source: Medscape Today Headlines)

A Drug That Prevents Breast Cancer, Without The Side Effects?
A common osteoporosis drug, raloxifene, reduces breast cancer risk by 38% in women at high risk for the disease, without causing the serious side effects of similar drugs, a new study shows. That suggests more high-risk women should consider taking raloxifene, also known as Evista, says Victor Vogel, main author of the study presented Monday at the American Association for Cancer Research meeting in Washington. (Source: Cancercompass News: Breast Cancer)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div